Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1985 1
1987 1
1988 1
1996 2
1997 1
1998 1
2003 2
2004 1
2006 2
2010 2
2011 3
2012 1
2014 1
2015 2
2017 2
2018 3
2019 3
2020 3
2022 2
2023 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

32 results

Results by year

Filters applied: . Clear all
Page 1
2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.
Grundy SM, Stone NJ, Bailey AL, Beam C, Birtcher KK, Blumenthal RS, Braun LT, de Ferranti S, Faiella-Tommasino J, Forman DE, Goldberg R, Heidenreich PA, Hlatky MA, Jones DW, Lloyd-Jones D, Lopez-Pajares N, Ndumele CE, Orringer CE, Peralta CA, Saseen JJ, Smith SC Jr, Sperling L, Virani SS, Yeboah J. Grundy SM, et al. Circulation. 2019 Jun 18;139(25):e1082-e1143. doi: 10.1161/CIR.0000000000000625. Epub 2018 Nov 10. Circulation. 2019. PMID: 30586774 Free PMC article.
In adults 40 to 75 years of age evaluated for primary ASCVD prevention, have a clinician-patient risk discussion before starting statin therapy. Risk discussion should include a review of major risk factors (eg, cigarette smoking, elevated blood …
In adults 40 to 75 years of age evaluated for primary ASCVD prevention, have a clinician-patient risk discussion before starting stat …
Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure.
Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, Jones DW, Materson BJ, Oparil S, Wright JT Jr, Roccella EJ; Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. National Heart, Lung, and Blood Institute; National High Blood Pressure Education Program Coordinating Committee. Chobanian AV, et al. Hypertension. 2003 Dec;42(6):1206-52. doi: 10.1161/01.HYP.0000107251.49515.c2. Epub 2003 Dec 1. Hypertension. 2003. PMID: 14656957
The National High Blood Pressure Education Program presents the complete Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. ...The key messages of this report are these: in those o …
The National High Blood Pressure Education Program presents the complete Seventh Report of the Joint National Committee on Pre …
Diabetes Management in Chronic Kidney Disease: Synopsis of the KDIGO 2022 Clinical Practice Guideline Update.
Navaneethan SD, Zoungas S, Caramori ML, Chan JCN, Heerspink HJL, Hurst C, Liew A, Michos ED, Olowu WA, Sadusky T, Tandon N, Tuttle KR, Wanner C, Wilkens KG, Craig JC, Tunnicliffe DJ, Tonelli M, Cheung M, Earley A, Rossing P, de Boer IH, Khunti K. Navaneethan SD, et al. Ann Intern Med. 2023 Mar;176(3):381-387. doi: 10.7326/M22-2904. Epub 2023 Jan 10. Ann Intern Med. 2023. PMID: 36623286 Free article.
DESCRIPTION: The KDIGO 2022 Clinical Practice Guideline for Diabetes Management in Chronic Kidney Disease is an update of the 2020 guideline from Kidney Disease: Improving Global Outcomes (KDIGO). ...To this are added additional drugs with heart and kidney pr …
DESCRIPTION: The KDIGO 2022 Clinical Practice Guideline for Diabetes Management in Chronic Kidney Disease is an update of the 2020 gu …
The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report.
Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, Jones DW, Materson BJ, Oparil S, Wright JT Jr, Roccella EJ; National Heart, Lung, and Blood Institute Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure; National High Blood Pressure Education Program Coordinating Committee. Chobanian AV, et al. JAMA. 2003 May 21;289(19):2560-72. doi: 10.1001/jama.289.19.2560. Epub 2003 May 14. JAMA. 2003. PMID: 12748199
"The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure" provides a new guideline for hypertension prevention and management. The following are the key messages(1) In persons older than 50 years, …
"The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure …
Managing Hypertension in the elderly: What's new?
Aronow WS. Aronow WS. Am J Prev Cardiol. 2020 May 1;1:100001. doi: 10.1016/j.ajpc.2020.100001. eCollection 2020 Mar. Am J Prev Cardiol. 2020. PMID: 34327445 Free PMC article. Review.
Hypertension is a major risk factor for cardiovascular events and mortality in the elderly. The 2017 American College of Cardiology/American Heart Association hypertension guidelines recommend treatment of noninstitutionalized ambulatory community-dwel …
Hypertension is a major risk factor for cardiovascular events and mortality in the elderly. The 2017 American College o …
Hypertension in Adults: Initial Evaluation and Management.
Clarke SL. Clarke SL. Am Fam Physician. 2023 Oct;108(4):352-359. Am Fam Physician. 2023. PMID: 37843942
The use of ambulatory and home blood pressure monitoring improves diagnostic accuracy. Assessment of adults with hypertension should focus on identifying complications of the condition and comorbid cardiovascular risk factors. ...Lowering blo …
The use of ambulatory and home blood pressure monitoring improves diagnostic accuracy. Assessment of adults with hypertension …
Physician perception of blood pressure control and treatment behavior in high-risk hypertensive patients: a cross-sectional study.
Banegas JR, Lundelin K, de la Figuera M, de la Cruz JJ, Graciani A, Rodríguez-Artalejo F, Puig JG. Banegas JR, et al. PLoS One. 2011;6(9):e24569. doi: 10.1371/journal.pone.0024569. Epub 2011 Sep 14. PLoS One. 2011. PMID: 21935425 Free PMC article.
OBJECTIVE: We examined physician perception of blood pressure control and treatment behavior in patients with previous cardiovascular disease and uncontrolled hypertension as defined by European Guidelines. ...Blood pressure level was the …
OBJECTIVE: We examined physician perception of blood pressure control and treatment behavior in patients with previous card …
Managing the elderly patient with hypertension: current strategies, challenges, and considerations.
Aronow WS. Aronow WS. Expert Rev Cardiovasc Ther. 2020 Feb;18(2):117-125. doi: 10.1080/14779072.2020.1732206. Epub 2020 Feb 23. Expert Rev Cardiovasc Ther. 2020. PMID: 32066287 Review.
Introduction: Hypertension is the leading modifiable risk factor for cardiovascular events and mortality in the world.Areas covered: An extensive literature review of articles and clinical trials on PUBMED on the topic of hypertension in the elderly from 1976 …
Introduction: Hypertension is the leading modifiable risk factor for cardiovascular events and mortality in the world.A …
Predictive role of the nighttime blood pressure.
Hansen TW, Li Y, Boggia J, Thijs L, Richart T, Staessen JA. Hansen TW, et al. Hypertension. 2011 Jan;57(1):3-10. doi: 10.1161/HYPERTENSIONAHA.109.133900. Epub 2010 Nov 15. Hypertension. 2011. PMID: 21079049 Free article. Review.
We reviewed prospective studies with total mortality or a composite cardiovascular end point as an outcome in relation to the level and the circadian profile of systolic BP. ...In the absence of conclusive evidence proving that nondipping is a reversible risk …
We reviewed prospective studies with total mortality or a composite cardiovascular end point as an outcome in relation to the level a …
Development of an Artificial Intelligence Model to Guide the Management of Blood Pressure, Fluid Volume, and Dialysis Dose in End-Stage Kidney Disease Patients: Proof of Concept and First Clinical Assessment.
Barbieri C, Cattinelli I, Neri L, Mari F, Ramos R, Brancaccio D, Canaud B, Stuard S. Barbieri C, et al. Kidney Dis (Basel). 2019 Feb;5(1):28-33. doi: 10.1159/000493479. Epub 2018 Nov 7. Kidney Dis (Basel). 2019. PMID: 30815462 Free PMC article. Review.
BACKGROUND: Fluid volume and blood pressure (BP) management are crucial endpoints for end-stage kidney disease patients. ...Achieving the optimal trade-off between adequate fluid removal and the risk of intradialytic adverse events is a complex task in …
BACKGROUND: Fluid volume and blood pressure (BP) management are crucial endpoints for end-stage kidney disease patients …
32 results